The University of Liverpool, the Royal Liverpool University Hospital (RLUH) and the Clatterbridge Centre for Oncology (CCO) are combining their cancer resources and facilities to provide better quality treatments for a broader range of cancers including head and neck, lung and lymphoma and enable international clinical trials of new cancer therapies.
It is planned that the merger will lead to the establishment of a Liverpool Experimental Cancer Medicine Centre (LECMC) to facilitate global clinical trials of new cancer therapies at their earliest stages (Stage I and II). This will allow for new drugs to be tested on a small group of patients, before being trialled with larger groups and internationally.
The centre, which will be funded by £750,000 from Cancer Research UK, will include the addition of six beds for cancer patients at RLUH to participate in cancer drugs trials as well as a new Chair of Medical Oncology, who will oversee the trials and related cancer research projects. The LECMC’s resources will also be accessible to external users in science and industry.
The LECMC will also be supported by a £1.1million transfer of six leading cancer specialists from the Clatterbridge Cancer Research Trust on Wirral to the University of Liverpool Cancer Research Centre (ULCRC). The team, led by Professor Ross Sibson, will work on cancer studies in areas such as breast cancer and neurological malignancies.
Professor John Caldwell, Dean of the Faculty of Medicine, said: “Liverpool plays a vital role in the development of new treatments for cancer – 15.2% of cancer patients in the area are recruited to trials – one of the highest rates in the UK. The merge with our cancer research partners will allow us to double the number of patients to early phase clinical trials as well as increase the capacity for treating cancer patients.”
The developments are part of an overall £20 million investment in cancer research and follow the recent launch of the University’s School of Cancer Studies – a newly created department focusing entirely on research for new cancer treatments and therapies, incorporating the former Divisions of Surgery and Oncology, Haematology; and Pathology.
Joanna Robotham | alfa
Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State
NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University
Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.
Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...
In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.
Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...
Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
09.12.2016 | Life Sciences
08.12.2016 | Life Sciences
08.12.2016 | Physics and Astronomy